Overview
Evidence-based recommendations on placental growth factor (PLGF)-based testing to help diagnose suspected preterm pre-eclampsia. The tests are: DELFIA Xpress PLGF 1‑2‑3, DELFIA Xpress sFlt‑1/PLGF 1‑2‑3 ratio, Elecsys immunoassay sFlt‑1/PLGF ratio, Triage PLGF Test.
Last reviewed: 27 July 2022
This guidance updates and replaces NICE diagnostics guidance 23.
Diagnostics guidance 49 has been migrated to HealthTech guidance 630.
Next review: This guidance will be reviewed if there is new evidence that is likely to change the recommendations.